Myocyte and myogenic stem cell transplantation in the heart

Cardiovascular Research

Volumn 58, Issue 2, 2003, Pages 336-350

  Dowell, Joshua D ^a   Rubart, Michael ^a   Pasumarthi, Kishore B S ^a   Soonpaa, Mark H ^a   Field, Loren J ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RILEY HOSPITAL FOR CHILDREN   (United States)

Author keywords

Cardiomyocytes; Cellular transplantation; Heart failure; Skeletal myoblasts; Stem cells

Indexed keywords

BETA GALACTOSIDASE; CARDIAC MYOSIN; DYSTROPHIN; HYGROMYCIN; NEOMYCIN; PROTEIN P53; THYMIDINE;

ALLOGRAFT; ANGIOGENESIS; AUTOTRANSPLANTATION; CARDIOMYOPATHY; CARDIOTOXICITY; CELL ACTIVITY; CELL CULTURE; CELL DIFFERENTIATION; CELL FATE; CELL LINE; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; COLD INJURY; CYTOLOGY; DISEASE MODEL; DNA MODIFICATION; DONOR; EMBRYO CELL; ENDOTHELIUM CELL; EXPERIMENTAL HOST; FETUS CELL; GENE EXPRESSION; GENE TRANSFER; GENETIC CODE; GENETIC DISORDER; GENETIC TRANSFECTION; GENETIC VARIABILITY; GRAFT SURVIVAL; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART INJURY; HEART MUSCLE; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOASSAY; IMMUNOLOGICAL MONITORING; ISOGRAFT; LIVER CELL; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; NERVE CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; REPORTER GENE; REVIEW; SKELETAL MUSCLE; STEM CELL; STEM CELL TRANSPLANTATION; TRANSGENE; XENOGRAFT; Y CHROMOSOME;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; HEART; HEART FAILURE, CONGESTIVE; MICROSCOPY, FLUORESCENCE; MODELS, ANIMAL; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; STEM CELL TRANSPLANTATION;

EID: 0038369113     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(03)00254-2     Document Type: Review

References (126)

1. SoRelle R. Myoblast transplant to heart attempted. Circulation. 102:2000;E9030-9031.
2. Strauer B.E., Brehm M., Zeus T., Kostering M., Hernandez A., Sorg R.V., et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation. 106:2002;1913-1918.
3. Soonpaa M.H., Koh G.Y., Klug M.G., Field L.J. Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science. 264:1994;98-101.
4. Koh G.Y., Soonpaa M.H., Klug M.G., Pride H.P., Cooper B.J., Zipes D.P., et al. Stable fetal cardiomyocyte grafts in the hearts of dystrophic mice and dogs. J Clin Invest. 96:1995;2034-2042.
5. Van Meter C.H. Jr., Claycomb W.C., Delcarpio J.B., Smith D.M., deGruiter H., Smart F., et al. Myoblast transplantation in the porcine model: a potential technique for myocardial repair. J Thorac Cardiovasc Surg. 110:1995;1442-1448.
6. Leor J., Patterson M., Quinones M.J., Kedes L.H., Kloner R.A. Transplantation of fetal myocardial tissue into the infarcted myocardium of rat. A potential method for repair of infarcted myocardium? Circulation. 94:1996;II332-336.
7. Li R.K., Jia Z.Q., Weisel R.D., Mickle D.A., Zhang J., Mohabeer M.K., et al. Cardiomyocyte transplantation improves heart function. Ann Thorac Surg. 62:1996;654-660. discussion pp. 660-661.
8. Connold A.L., Frischknecht R., Vrbova G. A simple method for cardiac surgery in rats. Cell Transplant. 5:1996;405-409.
9. Gojo S., Kitamura S., Germeraad W.T., Yoshida Y., Niwaya K., Kawachi K. Ex vivo gene transfer into myocardium using replication-defective retrovirus. Cell Transplant. 5:1996;S81-84.
10. Connold A.L., Frischknecht R., Dimitrakos M., Vrbova G. The survival of embryonic cardiomyocytes transplanted into damaged host rat myocardium. J Muscle Res Cell Motil. 18:1997;63-70.
11. Aoki M., Morishita R., Higaki J., Moriguchi A., Hayashi S., Matsushita H., et al. Survival of grafts of genetically modified cardiac myocytes transfected with FITC-labeled oligodeoxynucleotides and the β-galactosidase gene in the noninfarcted area, but not the myocardial infarcted area. Gene Ther. 4:1997;120-127.
12. Gojo S., Kitamura S., Hatano O., Takakusu A., Hashimoto K., Kanegae Y., et al. Transplantation of genetically marked cardiac muscle cells. J Thorac Cardiovasc Surg. 113:1997;10-18.
13. Scorsin M., Hagege A.A., Marotte F., Mirochnik N., Copin H., Barnoux M., et al. Does transplantation of cardiomyocytes improve function of infarcted myocardium? Circulation. 96:1997;II188-193.
14. Li R.K., Mickle D.A., Weisel R.D., Mohabeer M.K., Zhang J., Rao V., et al. Natural history of fetal rat cardiomyocytes transplanted into adult rat myocardial scar tissue. Circulation. 96:1997;II179-186. discussion 186-187.
15. Jia Z.Q., Mickle D.A., Weisel R.D., Mohabeer M.K., Merante F., Rao V., et al. Transplanted cardiomyocytes survive in scar tissue and improve heart function. Transplant Proc. 29:1997;2093-2094.
16. Scorsin M., Hagege A.A., Dolizy I., Marotte F., Mirochnik N., Copin H., et al. Can cellular transplantation improve function in doxorubicin-induced heart failure? Circulation. 98:1998;II151-155. discussion II155-156.
17. Watanabe E., Smith D.M. Jr., Delcarpio J.B., Sun J., Smart F.W., Van Meter C.H. Jr., et al. Cardiomyocyte transplantation in a porcine myocardial infarction model. Cell Transplant. 7:1998;239-246.
18. Sakai T., Li R.K., Weisel R.D., Mickle D.A., Jia Z.Q., Tomita S., et al. Fetal cell transplantation: a comparison of three cell types. J Thorac Cardiovasc Surg. 118:1999;715-724.
19. Reinecke H., Zhang M., Bartosek T., Murry C.E. Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation. 100:1999;193-202.
20. Li R.K., Jia Z.Q., Weisel R.D., Mickle D.A., Choi A., Yau T.M. Survival and function of bioengineered cardiac grafts. Circulation. 100:1999;II63-69.
21. Leor J., Aboulafia-Etzion S., Dar A., Shapiro L., Barbash I.M., Battler A., et al. Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium? Circulation. 102:2000;III56-61.
22. Scorsin M., Hagege A., Vilquin J.T., Fiszman M., Marotte F., Samuel J.L., et al. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J Thorac Cardiovasc Surg. 119:2000;1169-1175.
23. Li T.S., Hamano K., Kajiwara K., Nishida M., Zempo N., Esato K. Prolonged survival of xenograft fetal cardiomyocytes by adenovirus-mediated CTLA4-Ig expression. Transplantation. 72:2001;1983-1985.
24. Etzion S., Battler A., Barbash I.M., Cagnano E., Zarin P., Granot Y., et al. Influence of embryonic cardiomyocyte transplantation on the progression of heart failure in a rat model of extensive myocardial infarction. J Mol Cell Cardiol. 33:2001;1321-1330.
25. Yokomuro H., Li R.K., Mickle D.A., Weisel R.D., Verma S., Yau T.M. Transplantation of cryopreserved cardiomyocytes. J Thorac Cardiovasc Surg. 121:2001;98-107.
26. Sakakibara Y., Tambara K., Lu F., Nishina T., Sakaguchi G., Nagaya N., et al. Combined procedure of surgical repair and cell transplantation for left ventricular aneurysm: an experimental study. Circulation. 106:2002;I193-197.
27. Sakakibara Y., Tambara K., Lu F., Nishina T., Nagaya N., Nishimura K., et al. Cardiomyocyte transplantation does not reverse cardiac remodeling in rats with chronic myocardial infarction. Ann Thorac Surg. 74:2002;25-30.
28. Sakakibara Y., Nishimura K., Tambara K., Yamamoto M., Lu F., Tabata Y., et al. Prevascularization with gelatin microspheres containing basic fibroblast growth factor enhances the benefits of cardiomyocyte transplantation. J Thorac Cardiovasc Surg. 124:2002;50-56.
29. Ruhparwar A., Tebbenjohanns J., Niehaus M., Mengel M., Irtel T., Kofidis T., et al. Transplanted fetal cardiomyocytes as cardiac pacemaker. Eur J Cardiothorac Surg. 21:2002;853-857.
30. Roell W., Lu Z.J., Bloch W., Siedner S., Tiemann K., Xia Y., et al. Cellular cardiomyoplasty improves survival after myocardial injury. Circulation. 105:2002;2435-2441.
31. Rubart M, Soonpaa MH, Nakajima H, Nakajima H, Pasumarthi K, Field LJ. In-situ 2-photon microscopy reveals functional integration of grafted fetal cardiomyocytes in the adult host myocardium. American Heart Association 2002 Scientific Sessions, Abstract #104755.
32. Scorsin M., Marotte F., Sabri A., Le Dref O., Demirag M., Samuel J.L., et al. Can grafted cardiomyocytes colonize peri-infarct myocardial areas? Circulation. 94:1996;II337-340.
33. Matsushita T., Oyamada M., Kurata H., Masuda S., Takahashi A., Emmoto T., et al. Formation of cell junctions between grafted and host cardiomyocytes at the border zone of rat myocardial infarction. Circulation. 100:1999;II262-268.
34. Imanishi T., Murry C.E., Reinecke H., Hano T., Nishio I., Liles W.C., et al. Cellular FLIP is expressed in cardiomyocytes and down-regulated in TUNEL-positive grafted cardiac tissues. Cardiovasc Res. 48:2000;101-110.
35. Zhang M., Methot D., Poppa V., Fujio Y., Walsh K., Murry C.E. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol. 33:2001;907-921.
36. Miyagawa S., Sawa Y., Taketani S., Kawaguchi N., Nakamura T., Matsuura N., et al. Myocardial regeneration therapy for heart failure: hepatocyte growth factor enhances the effect of cellular cardiomyoplasty. Circulation. 105:2002;2556-2561.
37. Muller-Ehmsen J., Peterson K.L., Kedes L., Whittaker P., Dow J.S., Long T.I., et al. Rebuilding a damaged heart: long-term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function. Circulation. 105:2002;1720-1726.
38. Muller-Ehmsen J., Whittaker P., Kloner R.A., Dow J.S., Sakoda T., Long T.I., et al. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol. 34:2002;107-116.
39. Shimizu T., Yamato M., Isoi Y., Akutsu T., Setomaru T., Abe K., et al. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res. 90:2002;e40.
40. Eschenhagen T., Didie M., Heubach J., Ravens U., Zimmermann W.H. Cardiac tissue engineering. Transplant Immunol. 9:2002;315-321.
41. Sakai T., Li R.K., Weisel R.D., Mickle D.A., Kim E.J., Tomita S., et al. Autologous heart cell transplantation improves cardiac function after myocardial injury. Ann Thorac Surg. 68:1999;2074-2080. discussion pp. 2080-2081.
42. Yoo K.J., Li R.K., Weisel R.D., Mickle D.A., Jia Z.Q., Kim E.J., et al. Heart cell transplantation improves heart function in dilated cardiomyopathic hamsters. Circulation. 102:2000;III204-209.
43. Li R.K., Weisel R.D., Mickle D.A., Jia Z.Q., Kim E.J., Sakai T., et al. Autologous porcine heart cell transplantation improved heart function after a myocardial infarction. J Thorac Cardiovasc Surg. 119:2000;62-68.
44. Yau T.M., Fung K., Weisel R.D., Fujii T., Mickle D.A., Li R.K. Enhanced myocardial angiogenesis by gene transfer with transplanted cells. Circulation. 104:2001;I218-222.
45. Koh G.Y., Soonpaa M.H., Klug M.G., Field L.J. Long-term survival of AT-1 cardiomyocyte grafts in syngeneic myocardium. Am J Physiol. 264:1993;H1727-1733.
46. Delcarpio J.B., Claycomb W.C. Cardiomyocyte transfer into the mammalian heart. Cell-to-cell interactions in vivo and in vitro. Ann NY Acad Sci. 752:1995;267-285.
47. Koh G.Y., Klug M.G., Soonpaa M.H., Field L.J. Differentiation and long-term survival of C2C12 myoblast grafts in heart. J Clin Invest. 92:1993;1548-1554.
48. Koh G.Y., Kim S.J., Klug M.G., Park K., Soonpaa M.H., Field L.J. Targeted expression of transforming growth factor-beta 1 in intracardiac grafts promotes vascular endothelial cell DNA synthesis. J Clin Invest. 95:1995;114-121.
49. Robinson S.W., Cho P.W., Levitsky H.I., Olson J.L., Hruban R.H., Acker M.A., et al. Arterial delivery of genetically labelled skeletal myoblasts to the murine heart: long-term survival and phenotypic modification of implanted myoblasts. Cell Transplant. 5:1996;77-91.
50. Reinecke H., Murry C.E. Transmural replacement of myocardium after skeletal myoblast grafting into the heart. Too much of a good thing? Cardiovasc Pathol. 9:2000;337-344.
51. Suzuki K., Brand N.J., Smolenski R.T., Jayakumar J., Murtuza B., Yacoub M.H. Development of a novel method for cell transplantation through the coronary artery. Circulation. 102:2000;III359-364.
52. Suzuki K., Smolenski R.T., Jayakumar J., Murtuza B., Brand N.J., Yacoub M.H. Heat shock treatment enhances graft cell survival in skeletal myoblast transplantation to the heart. Circulation. 102:2000;III216-221.
53. Murry C.E., Wiseman R.W., Schwartz S.M., Hauschka S.D. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest. 98:1996;2512-2523.
54. Reinecke H., MacDonald G.H., Hauschka S.D., Murry C.E. Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair. J Cell Biol. 149:2000;731-740.
55. Jain M., DerSimonian H., Brenner D.A., Ngoy S., Teller P., Edge A.S., et al. Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation. 103:2001;1920-1927.
56. Marelli D., Desrosiers C., el-Alfy M., Kao R.L., Chiu R.C. Cell transplantation for myocardial repair: an experimental approach. Cell Transplant. 1:1992;383-390.
57. Marelli D., Ma F., Chiu R.C. Satellite cell implantation for neomyocardial regeneration. Transplant Proc. 24:1992;2995.
58. Zibaitis A., Greentree D., Ma F., Marelli D., Duong M., Chiu R.C. Myocardial regeneration with satellite cell implantation. Transplant Proc. 26:1994;3294.
59. Chiu R.C., Zibaitis A., Kao R.L. Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation. Ann Thorac Surg. 60:1995;12-18.
60. Yoon P.D., Kao R.L., Magovern G.J. Myocardial regeneration. Transplanting satellite cells into damaged myocardium. Tex Heart Inst J. 22:1995;119-125.
61. Taylor D.A., Silvestry S.C., Bishop S.P., Annex B.H., Lilly R.E., Glower D.D., et al. Delivery of primary autologous skeletal myoblasts into rabbit heart by coronary infusion: a potential approach to myocardial repair. Proc Assoc Am Phys. 109:1997;245-253.
62. Taylor D.A., Atkins B.Z., Hungspreugs P., Jones T.R., Reedy M.C., Hutcheson K.A., et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med. 4:1998;929-933.
63. Dorfman J., Duong M., Zibaitis A., Pelletier M.P., Shum-Tim D., Li C., et al. Myocardial tissue engineering with autologous myoblast implantation. J Thorac Cardiovasc Surg. 116:1998;744-751.
64. Atkins B.Z., Hueman M.T., Meuchel J., Hutcheson K.A., Glower D.D., Taylor D.A. Cellular cardiomyoplasty improves diastolic properties of injured heart. J Surg Res. 85:1999;234-242.
65. Atkins B.Z., Hueman M.T., Meuchel J.M., Cottman M.J., Hutcheson K.A., Taylor D.A. Myogenic cell transplantation improves in vivo regional performance in infarcted rabbit myocardium. J Heart Lung Transplant. 18:1999;1173-1180.
66. Atkins B.Z., Lewis C.W., Kraus W.E., Hutcheson K.A., Glower D.D., Taylor D.A. Intracardiac transplantation of skeletal myoblasts yields two populations of striated cells in situ. Ann Thorac Surg. 67:1999;124-129.
67. Hutcheson K.A., Atkins B.Z., Hueman M.T., Hopkins M.B., Glower D.D., Taylor D.A. Comparison of benefits on myocardial performance of cellular cardiomyoplasty with skeletal myoblasts and fibroblasts. Cell Transplant. 9:2000;359-368.
68. Lee R.J., Springer M.L., Blanco-Bose W.E., Shaw R., Ursell P.C., Blau H.M. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation. 102:2000;898-901.
69. Suzuki K., Murtuza B., Smolenski R.T., Sammut I.A., Suzuki N., Kaneda Y., et al. Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts. Circulation. 104:2001;I207-212.
70. Rajnoch C., Chachques J.C., Berrebi A., Bruneval P., Benoit M.O., Carpentier A. Cellular therapy reverses myocardial dysfunction. J Thorac Cardiovasc Surg. 121:2001;871-878.
71. Pouzet B., Vilquin J.T., Hagege A.A., Scorsin M., Messas E., Fiszman M., et al. Factors affecting functional outcome after autologous skeletal myoblast transplantation. Ann Thorac Surg. 71:2001;844-850. discussion pp. 850-851.
72. Chedrawy E.G., Wang J.S., Nguyen D.M., Shum-Tim D., Chiu R.C. Incorporation and integration of implanted myogenic and stem cells into native myocardial fibers: anatomic basis for functional improvements. J Thorac Cardiovasc Surg. 124:2002;584-590.
73. Dib N., Diethrich E.B., Campbell A., Goodwin N., Robinson B., Gilbert J., et al. Endoventricular transplantation of allogenic skeletal myoblasts in a porcine model of myocardial infarction. J Endovasc Ther. 9:2002;313-319.
74. Etzion S., Barbash I.M., Feinberg M.S., Zarin P., Miller L., Guetta E., et al. Cellular cardiomyoplasty of cardiac fibroblasts by adenoviral delivery of MyoD ex vivo: an unlimited source of cells for myocardial repair. Circulation. 106:2002;I125-130.
75. Suzuki K., Murtuza B., Heslop L., Morgan J.E., Smolenski R.T., Suzuki N., et al. Single fibers of skeletal muscle as a novel graft for cell transplantation to the heart. J Thorac Cardiovasc Surg. 123:2002;984-992.
76. Ghostine S., Carrion C., Souza L.C., Richard P., Bruneval P., Vilquin J.T., et al. Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation. 106:2002;I131-136.
77. Reinecke H., Poppa V., Murry C.E. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol. 34:2002;241-249.
78. Klug M.G., Soonpaa M.H., Koh G.Y., Field L.J. Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J Clin Invest. 98:1996;216-224.
79. Behfar A., Zingman L.V., Hodgson D.M., Rauzier J.M., Kane G.C., Terzic A., et al. Stem cell differentiation requires a paracrine pathway in the heart. FASEB J. 16:2002;1558-1566.
80. Min J.Y., Yang Y., Converso K.L., Liu L., Huang Q., Morgan J.P., et al. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J Appl Physiol. 92:2002;288-296.
81. Yang Y., Min J.Y., Rana J.S., Ke Q., Cai J., Chen Y., et al. VEGF enhances functional improvement of postinfarcted hearts by transplantation of ESC-differentiated cells. J Appl Physiol. 93:2002;1140-1151.
82. Tomita S., Li R.K., Weisel R.D., Mickle D.A., Kim E.J., Sakai T., et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation. 100:1999;II247-256.
83. Wang J.S., Shum-Tim D., Galipeau J., Chedrawy E., Eliopoulos N., Chiu R.C. Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J Thorac Cardiovasc Surg. 120:2000;999-1005.
84. Liechty K.W., MacKenzie T.C., Shaaban A.F., Radu A., Moseley A.M., Deans R., et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med. 6:2000;1282-1286.
85. Jackson K.A., Majka S.M., Wang H., Pocius J., Hartley C.J., Majesky M.W., et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest. 107:2001;1395-1402.
86. Murry C.E., Rubart M., Soonpaa M., Nakajima H., Nakajima H., Field L.J. Absence of cardiac differentiation in hematopoietic stem cells transplanted into normal and injured hearts. Circulation (abstract). 104:2001;II599.
87. Wang J.S., Shum-Tim D., Chedrawy E., Chiu R.C. The coronary delivery of marrow stromal cells for myocardial regeneration: pathophysiologic and therapeutic implications. J Thorac Cardiovasc Surg. 122:2001;699-705.
88. Strauer B.E., Brehm M., Zeus T., Gattermann N., Hernandez A., Sorg R.V., et al. [Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction]. Dtsch Med Wochenschr. 126:2001;932-938.
89. Orlic D., Kajstura J., Chimenti S., Jakoniuk I., Anderson S.M., Li B., et al. Bone marrow cells regenerate infarcted myocardium. Nature. 410:2001;701-705.
90. Hamano K., Li T.S., Kobayashi T., Hirata K., Yano M., Kohno M., et al. Therapeutic angiogenesis induced by local autologous bone marrow cell implantation. Ann Thorac Surg. 73:2002;1210-1215.
91. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 418:2002;41-49.
92. Mackenzie T.C., Shaaban A.F., Radu A., Flake A.W. Engraftment of bone marrow and fetal liver cells after in utero transplantation in MDX mice. J Pediatr Surg. 37:2002;1058-1064.
93. Saito T., Kuang J.Q., Bittira B., Al-Khaldi A., Chiu R.C. Xenotransplant cardiac chimera: immune tolerance of adult stem cells. Ann Thorac Surg. 74:2002;19-24. discussion p. 24.
94. Tomita S., Mickle D.A., Weisel R.D., Jia Z.Q., Tumiati L.C., Allidina Y., et al. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg. 123:2002;1132-1140.
95. Toma C., Pittenger M.F., Cahill K.S., Byrne B.J., Kessler P.D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 105:2002;93-98.
96. Wagers A.J., Sherwood R.I., Christensen J.L., Weissman I.L. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science. 297:2002;2256-2259.
97. Bittner R.E., Schofer C., Weipoltshammer K., Ivanova S., Streubel B., Hauser E., et al. Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat Embryol (Berlin). 199:1999;391-396.
98. Clarke D.L., Johansson C.B., Wilbertz J., Veress B., Nilsson E., Karlstrom H., et al. Generalized potential of adult neural stem cells. Science. 288:2000;1660-1663.
99. Condorelli G., Borello U., De Angelis L., Latronico M., Sirabella D., Coletta M., et al. Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: implications for myocardium regeneration. Proc Natl Acad Sci USA. 98:2001;10733-10738.
100. Malouf N.N., Coleman W.B., Grisham J.W., Lininger R.A., Madden V.J., Sproul M., et al. Adult-derived stem cells from the liver become myocytes in the heart in vivo. Am J Pathol. 158:2001;1929-1935.
101. Hierlihy A.M., Seale P., Lobe C.G., Rudnicki M.A., Megeney L.A. The post-natal heart contains a myocardial stem cell population. FEBS Lett. 530:2002;239.
102. Hruban R.H., Long P.P., Perlman E.J., Hutchins G.M., Baumgartner W.A., Baughman K.L., et al. Fluorescence in situ hybridization for the Y-chromosome can be used to detect cells of recipient origin in allografted hearts following cardiac transplantation. Am J Pathol. 142:1993;975-980.
103. Glaser R., Lu M.M., Narula N., Epstein J.A. Smooth muscle cells, but not myocytes, of host origin in transplanted human hearts. Circulation. 106:2002;17-19.
104. Laflamme M.A., Myerson D., Saffitz J.E., Murry C.E. Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ Res. 90:2002;634-640.
105. Muller P., Pfeiffer P., Koglin J., Schafers H.J., Seeland U., Janzen I., et al. Cardiomyocytes of noncardiac origin in myocardial biopsies of human transplanted hearts. Circulation. 106:2002;31-35.
106. Quaini F., Urbanek K., Beltrami A.P., Finato N., Beltrami C.A., Nadal-Ginard B., et al. Chimerism of the transplanted heart. New Engl J Med. 346:2002;5-15.
107. Orlic D., Kajstura J., Chimenti S., Limana F., Jakoniuk I., Quaini F., et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA. 98:2001;10344-10349.
108. Muller M., Fleischmann B.K., Selbert S., Ji G.J., Endl E., Middeler G., et al. Selection of ventricular-like cardiomyocytes from ES cells in vitro. FASEB J. 14:2000;2540-2548.
109. Rubart M, Pasumarthi K, Nakajima H, Nakajima HO, Soonpaa MH, Field LJ. Physiologic coupling of donor and host cardiomyocytes following cellular transplantation. 2003a: Circulation Research, under revision.
110. Rubart M, Wang E, Dunn KW, Field LJ. Two-photon molecular excitation imaging of Ca2+ transients in Langendorff-perfused mouse hearts. 2003b: American Journal of Physiology: Cell Physiology, in press.
111. Soonpaa M.H., Field L.J. Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ Res. 83:1998;15-26.
112. Li R.K., Yau T.M., Weisel R.D., Mickle D.A., Sakai T., Choi A., et al. Construction of a bioengineered cardiac graft. J Thorac Cardiovasc Surg. 119:2000;368-375.
113. Kim E.J., Li R.K., Weisel R.D., Mickle D.A., Jia Z.Q., Tomita S., et al. Angiogenesis by endothelial cell transplantation. J Thorac Cardiovasc Surg. 122:2001;963-971.
114. Nakano M., Nakajima Y., Kudo S., Tsuchida Y., Nakamura H., Fukuda O. Successful autotransplantation of microvessel fragments into the rat heart. Eur Surg Res. 31:1999;240-248.
115. Li R.K., Jia Z.Q., Weisel R.D., Merante F., Mickle D.A. Smooth muscle cell transplantation into myocardial scar tissue improves heart function. J Mol Cell Cardiol. 31:1999;513-522.
116. Yoo K.J., Li R.K., Weisel R.D., Mickle D.A., Li G., Yau T.M. Autologous smooth muscle cell transplantation improved heart function in dilated cardiomyopathy. Ann Thorac Surg. 70:2000;859-865.
117. Yoo K.J., Li R.K., Weisel R.D., Mickle D.A., Tomita S., Ohno N., et al. Smooth muscle cells transplantation is better than heart cells transplantation for improvement of heart function in dilated cardiomyopathy. Yonsei Med J. 43:2002;296-303.
118. Kocher A.A., Schuster M.D., Szabolcs M.J., Takuma S., Burkhoff D., Wang J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med. 7:2001;430-436.
119. Tillisch J., Brunken R., Marshall R., Schwaiger M., Mandelkern M., Phelps M., et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. New Engl J Med. 314:1986;884-888.
120. Kloner R.A., Jennings R.B. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1. Circulation. 104:2001;2981-2989.
121. Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol. 33:2001;1897-1918.
122. Kang P.M., Yue P., Izumo S. New insights into the role of apoptosis in cardiovascular disease. Circ J. 66:2002;1-9.
123. Pasumarthi K.B., Field L.J. Cardiomyocyte cell cycle regulation. Circ Res. 90:2002;1044-1054.
124. Pasumarthi KBS, Daud AI, Field LJ. Regulation of cardiomyocyte proliferation and apoptosis. In: Crescenzi M, editor. Reactivation of the Cell Cycle in Terminally Differentiated Cells, Landes Biosciences, Inc., 2002, pp. 11-27.
125. Pasumarthi K.B., Tsai S.C., Field L.J. Coexpression of mutant p53 and p193 renders embryonic stem cell-derived cardiomyocytes responsive to the growth-promoting activities of adenoviral E1A. Circ Res. 88:2001;1004-1011.
126. Kaplon R., Lombardi P. Passive constraint and new shape-change devices for heart failure. Semin Thorac Cardiovasc Surg. 14:2002;150-156.